Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 104
of 6Next
1:

Skeletal muscle munc18c and syntaxin 4 in human obesity.

Bergman BC, Cornier MA, Horton TJ, Bessesen DH, Eckel RH.

Nutr Metab (Lond). 2008 Jul 24;5:21.

PMID: 18652694 [PubMed - in process]

2:

Effects of fasting on insulin action and glucose kinetics in lean and obese men and women.

Bergman BC, Cornier MA, Horton TJ, Bessesen DH.

Am J Physiol Endocrinol Metab. 2007 Oct;293(4):E1103-11. Epub 2007 Aug 7.

PMID: 17684102 [PubMed - indexed for MEDLINE]

3:

Ceramide content is increased in skeletal muscle from obese insulin-resistant humans.

Adams JM 2nd, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, Sullards MC, Mandarino LJ.

Diabetes. 2004 Jan;53(1):25-31.

PMID: 14693694 [PubMed - indexed for MEDLINE]

4:

Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.

Pendergrass M, Koval J, Vogt C, Yki-Jarvinen H, Iozzo P, Pipek R, Ardehali H, Printz R, Granner D, DeFronzo RA, Mandarino LJ.

Diabetes. 1998 Mar;47(3):387-94.

PMID: 9519744 [PubMed - indexed for MEDLINE]

5:

Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects.

Kruszynska YT, Mulford MI, Baloga J, Yu JG, Olefsky JM.

Diabetes. 1998 Jul;47(7):1107-13.

PMID: 9648835 [PubMed - indexed for MEDLINE]

6:

Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.

Miele C, Formisano P, Condorelli G, Caruso M, Oriente F, Andreozzi F, Tocchetti CG, Riccardi G, Beguinot F.

Diabetologia. 1997 Apr;40(4):421-9.

PMID: 9112019 [PubMed - indexed for MEDLINE]

7:

The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.

Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM.

Diabetes. 2002 Oct;51(10):2968-74.

PMID: 12351435 [PubMed - indexed for MEDLINE]

8:

Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle.

Clerk LH, Vincent MA, Jahn LA, Liu Z, Lindner JR, Barrett EJ.

Diabetes. 2006 May;55(5):1436-42.

PMID: 16644702 [PubMed - indexed for MEDLINE]

9:

Adipose tissue, hepatic, and skeletal muscle insulin sensitivity in extremely obese subjects with acanthosis nigricans.

Reeds DN, Stuart CA, Perez O, Klein S.

Metabolism. 2006 Dec;55(12):1658-63.

PMID: 17142140 [PubMed - indexed for MEDLINE]

10:

Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.

Kruszynska YT, Olefsky JM, Frias JP.

Metabolism. 2003 Feb;52(2):233-8.

PMID: 12601639 [PubMed - indexed for MEDLINE]

11:

Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.

Bergeron R, Previs SF, Cline GW, Perret P, Russell RR 3rd, Young LH, Shulman GI.

Diabetes. 2001 May;50(5):1076-82.

PMID: 11334411 [PubMed - indexed for MEDLINE]

12:

Relationship between plasma free fatty acids and uncoupling protein-3 gene expression in skeletal muscle of obese subjects: in vitro evidence of a causal link.

Sbraccia P, D'Adamo M, Leonetti F, Buongiorno A, Silecchia G, Basso MS, Tamburrano G, Lauro D, Federici M, Di Daniele N, Lauro R.

Clin Endocrinol (Oxf). 2002 Aug;57(2):199-207.

PMID: 12153598 [PubMed - indexed for MEDLINE]

13:

The effects of short-term overfeeding on insulin action in lean and reduced-obese individuals.

Cornier MA, Bergman BC, Bessesen DH.

Metabolism. 2006 Sep;55(9):1207-14.

PMID: 16919540 [PubMed - indexed for MEDLINE]

14:

Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.

Chung JW, Suh KI, Joyce M, Ditzler T, Henry RR.

Diabetes Care. 1995 May;18(5):666-73.

PMID: 8586004 [PubMed - indexed for MEDLINE]

15:

NIDDM in the elderly.

Meneilly GS, Elliott T, Tessier D, Hards L, Tildesley H.

Diabetes Care. 1996 Dec;19(12):1320-5.

PMID: 8941457 [PubMed - indexed for MEDLINE]

16:

Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion.

Jessen N, Djurhuus CB, Jørgensen JO, Jensen LS, Møller N, Lund S, Schmitz O.

Am J Physiol Endocrinol Metab. 2005 Jan;288(1):E194-9. Epub 2004 Aug 31.

PMID: 15339744 [PubMed - indexed for MEDLINE]

17:

Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects.

Serlie MJ, Meijer AJ, Groener JE, Duran M, Endert E, Fliers E, Aerts JM, Sauerwein HP.

J Clin Endocrinol Metab. 2007 Apr;92(4):1524-9. Epub 2007 Jan 30.

PMID: 17264178 [PubMed - indexed for MEDLINE]

18:

Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.

Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, Buzzigoli E, Sironi AM, Cersosimo E, Ferrannini E, Defronzo RA.

Gastroenterology. 2007 Aug;133(2):496-506. Epub 2007 May 1.

PMID: 17681171 [PubMed - indexed for MEDLINE]

19:

Kinetics of in vivo muscle insulin-mediated glucose uptake in human obesity.

Laakso M, Edelman SV, Olefsky JM, Brechtel G, Wallace P, Baron AD.

Diabetes. 1990 Aug;39(8):965-74.

PMID: 2197140 [PubMed - indexed for MEDLINE]

20:

Troglitazone improves insulin-stimulated glucose utilization associated with an increased muscle glycogen content in obese Zucker rats.

Oshida Y, Kako M, Nakai N, Shimomura Y, Li L, Sato J, Ohsawa I, Sato Y.

Endocr J. 1999 Oct;46(5):723-30.

PMID: 10670760 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 104
of 6Next